Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment

Arthritis and Rheumatism

Volumn 54, Issue 7, 2006, Pages 2109-2118

  Toh, Myew Ling ^a   Marotte, Hubert ^a   Blond, Jean Luc ^a   Jhumka, Umar ^a   Eljaafari, Assia ^a   Mougin, Bruno ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; INFLIXIMAB; INTERLEUKIN 1BETA; METHOTREXATE; SYNOVIOLIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CD3+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CHRONICITY; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DRUG INFUSION; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FIBROBLAST; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIOCYTE; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 33745911149     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21926     Document Type: Article

References (35)

1. Firestein G. Evolving concepts of rheumatoid arthritis [editorial]. Nature 2003;423:356-61.
2. Firestein G, Echeverri F, Yeo M, Zvaifler N, Green D. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94:10895-900.
3. Inazuka M, Tahira T, Horiuchi T, Harashima S, Sawabe T, Kondo M, et al. Analysis of p53 tumor suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology 2000;39:262-6.
4. Reme T, Travaglio A, Gueydon E, Adla E, Jorgensen C, Sany J. Mutations of p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 1998;111:353-8.
5. Kullmann F, Judex M, Neudecker I, Lechner S, Justen H, Green DR, et al. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 1999;42:1594-600.
6. Sun Y, Cheung H. p53. proto-oncogene and rheumatoid arthritis. Semin Arthritis Rheum 2002;31:299-310.
7. Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, Kawahara K, et al. Synoviolin/Hrd1, an E3 uhiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 2003;17:2436-49.
8. Kaneko M, Ishiguro M, Nünuma Y, Uesug M, Nomura Y. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett 2002;532:147-52.
9. Kaneko M, Yasuyuki N. ER signaling in unfolded protein response. Life Sci 2003;74:199-205.
10. Welihinda A, Tirasophon W, Kaufman R. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr 1999;7:293-300.
11. Hampton R. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 2002;14:476-82.
12. Meusser B, Hirsch C, Karosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol 2005;7:766-72.
13. Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest 2002;110:1383-8.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Pulte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
16. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
17. Gonzalez-Barderas M, Gallego-Delgado J, Mas S, Duran M, Eazaro A, Hernandez-Merida S, et al. Isolation of circulating human monocytes with high purity for proteomic analysis. Proteomics 2004;4:432-7.
18. Toh ML, Hong SS, van de Loo F, Franqueville L, Lindholm L, van den Berg W, et al. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins. J Immunol 2005;175:7687-98.
19. Pachot A, Blond J, Mougin B, Miossec P. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 2004;114:121-4.
20. Toh ML, Yang Y, Leech M, Santos L, Morand EF. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1β and glucocorticoids. Arthritis Rheum 2004;50:3118-28.
21. Zvaifler NJ, Firestein GF. Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis [editorial]. Arthritis Rheum 1994;37:783-9.
22. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenhaum JT. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining [editorial]. Arthritis Rheum 1994;37:212-20.
23. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
24. Kikkert M, Doolman R, Dai M, Avner R, Hassink G, van Voorden S, et al. Human HRD1 is an E3 uhiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem 2004;279:3525-34.
25. Nadav E, Shmueli A, Barr H, Gonen H, Ciechanover A, Reiss Y. A novel mammalian endoplasmic recticulum uhiquitin ligase homologous to the yeast Hrd1. Biochem Biophys Res Commun 2003;28:91-7.
26. Yagishita N, Ohneda K, Amano T, Yamasaki S, Sugiura A, Tsuchimochi K, et al. Essential role of synoviolin in embryogenesis. J Biol Chem 2005;280:7909-16.
27. Buch M, Conaghiin P, Quinn M, Bingham S, Veale D, Emery P. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin α? Ann Rheum Dis 2004;63:1344-6.
28. Miossec P. IL-17 in rheumutoid arthritis: a new target for treatment or just another cytokine? Joint Bone Spine 2004;71:87-90.
29. Morand E, Leech M, Weedon H, Metz C, Bucala R, Smith M. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002;41:558-62.
30. Hahn G, Stuhlmuller B, Hain N, Kalden J, Pfizenmaier K, Burmester G. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 1993;91:862-70.
31. Stuhlmuller B, Ungethum U, Scholze S, Martinez L, Backhaus M, Kraetsch H, et al. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 2000;43:775-90.
32. Maini R, Feldmann M. How does infliximab work in rheumatoid arthritis? Arthritis Res 2002;4:S22-8.
33. Feldmann M, Maini R. Anli-TNFα therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96.
34. Catrina AI, Trollmo C, Klint E, Engstrom M, Lampa J, Hermansson Y, et al. Evidence that anti-tumor necrosis factor therapy with both elanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 2005;52:61-72.
35. Kawaida R, Yamada R, Kobayashi K, Tokuhiro S, Suzuki A, Kochi Y, et al. CUL1, a component of E3 uhiquitin ligase, alters lymphocyte signal transduction with possible effect on rheumatoid arthritis. Genes Immun 2005;6:194-202.